Trident Lifeline Limited will participate in the Arihant Capital Bharat Connect Virtual Conference Rising Star 2026 on Friday, September 25, 2026. The management team is scheduled to engage with investors and analysts during the group meeting.

The virtual conference is set to begin at 10:00 am. The company disclosed its participation pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure requirements) Regulation, 2015.

Meeting Details

The schedule for the meeting is subject to change due to exigencies on the part of the fund, broking house, or the company.

Disclosure Guidelines

Discussions with investors and analysts will be based on generally available information. The company stated that the interaction will not involve any unpublished price-sensitive information, in accordance with its Code of Practices and Procedures for Fair Disclosure of Unpublished Price-Sensitive Information.

For further details, stakeholders may visit the company’s website at www.tridentlifeline.com .

Trident Lifeline has scheduled its 13th Annual General Meeting for September 26, 2026. The meeting will convene via video conferencing to transact ordinary and special business items.

The primary agenda includes the adoption of the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026. During FY26, consolidated revenue from operations grew 48% to ₹129.0 crore, while profit after tax rose 84% to ₹19.3 crore. The consolidated EBITDA margin expanded by 470 basis points to 21.8%.

Corporate Governance and Remuneration

Shareholders will vote on the re-appointment of Hardik Jigishkumar Desai as a director, who retires by rotation. The Board also seeks approval for managerial remuneration that may exceed statutory limits under Section 197 of the Companies Act, 2013.

Additionally, the meeting will consider a special resolution to waive the recovery of excess remuneration paid to Executive Director Ashish Anandsingh Bafna. The Board noted that ₹6.37 lakh paid to him during FY26 exceeded the maximum permissible limit prescribed under the Act. The waiver is subject to shareholder approval via special resolution.

Related Party Transactions

The AGM will approve related party transactions for the financial year 2026-27. The Board seeks prior approval for transactions with subsidiaries and entities in which directors have an interest. Key related parties include Trident Mediquip Limited, TLL Parenterals Limited, and Talon Healthcare LLP.

The maximum aggregate value for transactions with Trident Mediquip Limited and TLL Parenterals Limited is set at ₹100.00 crore each annually. Transactions with other entities such as TNS Pharma Private Limited and TLL Wellness Limited are capped at ₹50.00 crore per annum. All transactions are intended to be conducted at arm's length.

Meeting Logistics

The cut-off date for determining voting rights is September 19, 2026. Remote e-voting will be available from September 23, 2026, to September 25, 2026. The company has appointed CS Mehul Amareliya as the scrutinizer for the e-voting process.